1. Home
  2. Volume 03 Issue 11 November 2024
  3. November 2024

November 2024

Community Diagnosis in Efforts to Reduce the Number of Hypertension in the Gembong Health Center Work Area, Tangerang Regency, Banten Province, Indonesia

1Beatta Ardena Vici Vidheashinta Mutiara, 2Oktavia Setyaningrum, 3Sherin Dessyana Chrystin, 4Muhamad Shodiqul Amin, 5Tom Surjadi
1,2,3,4,5Faculty of Medicine, Universitas Tarumanagara, Indonesia
DOI : https://doi.org/10.58806/ijirme.2024.v3i11n04

Abstract

Hypertension is diagnosed when a person's systolic blood pressure is ≥140 mmHg or diastolic blood pressure (DBP) is ≥90 mmHg after at least two examinations. Hypertension ranks first for 10 cases of non-communicable diseases in the Gembong Health Center Work Area. This study aimed to analyze the decrease in the number of hypertension cases in the Gembong Health Center work area, Balaraja District, Tangerang Regency, Banten Province. The method used is a community diagnosis approach that identifies problems using the Blum Paradigm. Problem priorities are determined using the Delphi non-scoring technique, and the root cause of the problem is determined using a fishbone diagram. Intervention result data were obtained through pre-and post-test questionnaires. Monitoring was carried out with a plan-do-check-action (PDCA) cycle. The evaluation was carried out using a systems approach. Based on the analysis results using a fishbone diagram, the main problem is the lack of public knowledge regarding hypertension. The results of the counselling showed that all participants scored ≥ 70 points on the post-test, and blood pressure measurement screening showed that 9 (45%) participants suffered from hypertension. The community diagnosis approach implemented can increase public knowledge about hypertension.

Keywords:

Hypertension, Community Diagnosis, Society and Health.

References:

1) Chakraborty, D. S., Lahiry, S., & Choudhury, S. (2021). Hypertension Clinical Practice Guidelines (ISH, 2020): What Is New? Medical Principles and Practice, 30(6), 579–584. https://doi.org/10.1159/000518812

2) Dueñas, R. M., Jara, L. N., Ramis, F., Fuentes-Cáceres, V., & Núñez, A. (2023). Priorities and root cause analysis of quality and safety problems in chilean hospitals. Rev Med Chile, 151, 139–150.

3) Dwi Maharani, G., Nur’aeni, A., & Purnama, D. (2024). DESCRIPTION OF BLOOD PRESSURE AND HEALTHY LIFESTYLE BEHAVIOR AMONG EMPLOYEES. Indonesian Journal of Global Health Research, 6(6), 3745–3754. https://doi.org/10.37287/ijghr.v6i6.3908

4) Flack, J. M., Buhnerkempe, M. G., & Moore, K. T. (2024). Resistant Hypertension: Disease Burden and Emerging Treatment Options. Current Hypertension Reports, 26(5), 183–199. https://doi.org/10.1007/s11906-023-01282-0

5) Granados-Gámez, G., Roales-Nieto, J. G., Gil-Luciano, A., Moreno-San Pedro, E., & Márquez-Hernández, V. V. (2015). A longitudinal study of symptoms beliefs in hypertension. International Journal of Clinical and Health Psychology, 15(3), 200–207. https://doi.org/10.1016/j.ijchp.2015.07.001

6) Ma, J., & Chen, X. (2022). Advances in pathogenesis and treatment of essential hypertension. Frontiers in Cardiovascular Medicine, 9, 1–12. https://doi.org/10.3389/fcvm.2022.1003852

7) Mancia, G., Kreutz, R., Brunstr, M., Burnier, M., Grassi, G., Januszewicz, A., Lorenza Muiesan, M., Tsioufis, K., Agabiti-Rosei, E., Abd Elhady Algharably, E., Azizi, M., Benetos, A., Borghi, C., Brguljan Hitij, J., Cifkova, R., Coca, A., Cornelissen, V., Kennedy Cruickshank, J., Cunha, P. G., … Kjeldsen uuu, S. E. (2023). 2023 ESH Guidelines for the management of arterial hypertension. Journal of Hypertension, 41(12), 1874–2071. http://journals.lww.com/jhypertension

8) Nara Fadhilla, S., & Permana, D. (2020). The use of antihypertensive drugs in the treatment of essential hypertension at outpatient installations, Puskesmas Karang Rejo, Tarakan. Yarsi Journal of Pharmacology , 1(1), 7–14.

9) Saxena, T., Ozefa Ali, A., & Saxena, M. (2021). Essential Hypertension: Pathophysiology& Management (Current View). Cardiology and Cardiovascular Medicine, 5(1), 57–60. https://doi.org/10.26502/fccm.92920181

10) Shere, A., Eletta, O., & Goyal, H. (2017). Circulating blood biomarkers in essential hypertension: a literature review. Journal of Laboratory and Precision Medicine, 99(2), 1–11. https://doi.org/10.21037/jlpm.2017.12.06

11) Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., Wainford, R. D., Williams, B., & Schutte, A. E. (2020). 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension, 75(6), 1334–1357. https://doi.org/10.1161/HYPERTENSIONAHA.120.15026